|
🐜
|
Class II HLA interactions modulate genetic risk for multiple sclerosis
56 auth.
L. Moutsianas,
L. Jostins,
Ashley H Beecham,
A. Dilthey,
Dionysia K. Xifara,
M. Ban,
T. Shah,
N. Patsopoulos,
L. Alfredsson,
C. Anderson,
K. Attfield,
S. Baranzini,
J. Barrett,
T. Binder,
D. Booth,
...
D. Buck,
E. Celius,
C. Cotsapas,
S. D'alfonso,
C. Dendrou,
P. Donnelly,
B. Dubois,
B. Fontaine,
L. Fugger,
A. Goris,
P. Gourraud,
C. Graetz,
B. Hemmer,
J. Hillert,
International IBD Genetics Consortium (IIBDGC),
I. Kockum,
S. Leslie,
C. Lill,
F. Martinelli-Boneschi,
J. Oksenberg,
T. Olsson,
A. Oturai,
J. Saarela,
H. Søndergaard,
A. Spurkland,
B. Taylor,
J. Winkelmann,
F. Zipp,
J. Haines,
M. Pericak-Vance,
C. Spencer,
G. Stewart,
D. Hafler,
A. Ivinson,
H. Harbo,
S. Hauser,
P. D. De Jager,
Alastair Compston,
J. McCauley,
S. Sawcer,
G. McVean
|
8 |
2015 |
8
🐜
|
|
🐜
|
HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis
25 auth.
Jian Wang,
I. Jelcic,
L. Mühlenbruch,
V. Haunerdinger,
Nora C. Toussaint,
Yingdong Zhao,
C. Cruciani,
W. Faigle,
Reza Naghavian,
M. Foege,
T. Binder,
T. Eiermann,
L. Opitz,
Laura Fuentes-Font,
R. Reynolds,
...
W. Kwok,
J. Nguyen,
Jar-how Lee,
A. Lutterotti,
C. Münz,
H. Rammensee,
Mathias M. Hauri-Hohl,
M. Sospedra,
S. Stevanović,
Roland Martin
|
7 |
2020 |
7
🐜
|
|
🐜
|
Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR‐ligand mismatch after dose‐reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma
18 auth.
N. Kröger,
B. Shaw,
S. Iacobelli,
T. Zabelina,
K. Peggs,
A. Shimoni,
A. Nagler,
T. Binder,
T. Eiermann,
A. Madrigal,
...
R. Schwerdtfeger,
M. Kiehl,
H. Sayer,
J. Beyer,
M. Bornhäuser,
F. Ayuk,
A. Zander,
D. Marks
|
6 |
2005 |
6
🐜
|
|
🐜
|
Low Number of Donor Activating Killer Immunoglobulin-Like Receptors (KIR) Genes but not KIR-Ligand Mismatch Prevents Relapse and Improves Disease-Free Survival in Leukemia Patients After In Vivo T-Cell Depleted Unrelated Stem Cell Transplantation
10 auth.
N. Kröger,
T. Binder,
T. Zabelina,
C. Wolschke,
H. Schieder,
H. Renges,
...
F. Ayuk,
J. Dahlke,
T. Eiermann,
A. Zander
|
6 |
2006 |
6
🐜
|
|
🐜
|
Long-term Clinical Relevance of De Novo Donor-Specific Antibodies After Pediatric Liver Transplantation
10 auth.
E. Grabhorn,
T. Binder,
D. Obrecht,
F. Brinkert,
A. Lehnhardt,
U. Herden,
...
S. Peine,
B. Nashan,
R. Ganschow,
A. Briem-Richter
|
5 |
2015 |
5
🐜
|
|
🐜
|
HLA-DR15-derived self-peptides are involved in increased autologous T cell proliferation in multiple sclerosis.
10 auth.
M. Mohme,
C. Hotz,
S. Stevanović,
T. Binder,
Jar-how Lee,
M. Okoniewski,
...
T. Eiermann,
M. Sospedra,
H. Rammensee,
Roland Martin
|
5 |
2013 |
5
🐜
|
|
🐜
|
5-Azacytidine Promotes an Inhibitory T-Cell Phenotype and Impairs Immune Mediated Antileukemic Activity
8 auth.
T. Stübig,
A. Badbaran,
T. Luetkens,
York Hildebrandt,
D. Atanackovic,
T. Binder,
...
B. Fehse,
N. Kröger
|
5 |
2014 |
5
🐜
|
|
🐜
|
HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.
11 auth.
N. Kröger,
T. Zabelina,
T. Binder,
F. Ayuk,
U. Bacher,
Gitta Amtsfeld,
...
Heinrich Lellek,
J. Schrum,
R. Erttmann,
T. Eiermann,
A. Zander
|
5 |
2009 |
5
🐜
|
|
🐜
|
Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
13 auth.
F. Ayuk,
Galina Diyachenko,
T. Zabelina,
J. Panse,
C. Wolschke,
T. Eiermann,
T. Binder,
B. Fehse,
R. Erttmann,
H. Kabisch,
...
U. Bacher,
N. Kröger,
A. Zander
|
5 |
2008 |
5
🐜
|
